Abstract
No public abstract is available from the verified source records.
Philip Curman, M. Thapa, Ralf J. Ludwig, M. Kasperkiewicz
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Development of psoriasis during treatment with dupilumab: a systematic review
10.1016/j.jaad.2021.05.013 · 2022
Psoriasis risk in patients with atopic dermatitis treated with dupilumab
10.1001/jamadermatol.2025.1578 · 2025
Evaluation of dupilumab in patients with bullous pemphigoid
10.1001/jamadermatol.2023.2428 · 2023
10.1111/ddg.70397
10.1111/ddg.70397
Dupilumab for bullous pemphigoid: umbrella review of systematic reviews and meta‐analyses
10.1016/j.jdin.2025.10.004 · 2025
Dupilumab for bullous pemphigoid: umbrella review of systematic reviews and meta‐analyses
10.1016/j.jdin.2025.10.004 · doi-reference
10.1111/ddg.70397
10.1111/ddg.70397 · doi-reference
Evaluation of dupilumab in patients with bullous pemphigoid
10.1001/jamadermatol.2023.2428 · doi-reference
Psoriasis risk in patients with atopic dermatitis treated with dupilumab
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
datacite
Confidence 0%
10.1001/jamadermatol.2025.1578 · doi-reference
Development of psoriasis during treatment with dupilumab: a systematic review
10.1016/j.jaad.2021.05.013 · doi-reference